Enfermedades bullosas

  1. Pulido Pérez, A.
  2. Suárez Fernández, Ricardo
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2014

Issue Title: Enfermedades de la piel (I): dermatosis infecciosas, descamativas, bullosas y sistémicas

Series: 11

Issue: 47

Pages: 2774-2782

Type: Article

DOI: 10.1016/S0304-5412(14)70696-1 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Bullous or bullous diseases represent a complex group of entities with common clinical features and different pathogenic mechanisms. Affecting the skin, mucous membranes and, occasionally, other epithelial tissues. Pemphigus and pemphigoid belong to the group of autoimmune bullous diseases. Despite its low incidence, have a high morbidity, so that knowledge of its main features is essential in clinical practice. Diagnosis should be made based on clinical findings, immunopathology and serology. Corticosteroids and immunosuppressive star in traditional therapeutic regimens. However, in recent years, new therapies have been developed which block the production of autoantibodies in these diseases and significantly decrease the side effects of chronic use of steroids and other immunosuppressive agents.

Bibliographic References

  • Ambros-Rudolph CM. Dermatoses of pregnancy : clues to diagnosis, fetal risk and therapy. Ann Dermatol. 2011;23:265-75.
  • Ameri P, Cinotti E, Mussap M, Murialdo G, Parodi A, Cozzani E. Association of pemphigus and bullous pemphigoid with thyroid autoimmunity in Caucasian patients. J Am Acad Dermatol. 2013;68:687-9.
  • Aoki V, Sousa JX Jr, Diaz LA; Cooperative Group on Fogo Selvagem Research. Pathogenesis of endemic pemphigus foliaceus. Dermatol Clin. 2011;29:413-8
  • Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Blood. 2012;120:4496-504.
  • Barreiro-Capurro A, Mascaró-Galy JM, Iranzo P. Retrospective study of the clinical, histologic, and immunologic features of epidermolysis bullosa acquisita in 9 patients. Actas Dermosifiliogr. 2013;104(10):904-14.
  • Bernard P, Antonicelli F, Bedane C, Joly P, Le Roux-Villet C, Duvert-Lehembre S. Prevalence and clinical significance of antilaminin 332 autoantibodies detected by a novel enzyme linked immunosorbent assay in mucous membrane pemphigoid. JAMA Dermatol. 2013;149:533-40.
  • Bhanusali DG, Sachdev A, Rahmanian A, Gerlach JA, Tong JC, Seiffert-Sinha K. HLA-E*0103X is associated with susceptibility to Pemphigus vulgaris. Exp Dermatol. 2013;22:108-12.
  • Campos Domínguez M, Suárez Fernández R, Lázaro Ochaita P. Diagnostic methods in autoimmune subepidermal bullous diseases. Actas Dermosifiliogr. 2006;97:485-502.
  • Chan LS. Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid). Clin Dermatol. 2012;30:34-7.
  • Chanal J, Ingen-Housz-Oro S, Ortonne N, Duong TA, Thomas M, Valeyrie-Allanore L. Linear IgA bullous dermatosis: comparison bet-ween drug induced and spontaneous forms. Br J Dermatol. 2013;169(5): 1041-8.
  • Doffoel-Hantz V, Cogné M, Sparsa A, Bonnetblanc JM, Drouet M, Bédane C. Physiopathology of herpetiform dermatitis. Current data. Ann Dermatol Venereol. 2008;135:784-8.
  • El Tal AK, Posner MR, Spigelman Z, Ahmed AR. Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris. J Am Acad Dermatol. 2006;55:449-59.
  • Fania L, Zampetti A, Guerriero G, Feliciani C. Alteration of cholinergic system in keratinocytes cells produces acantholysis: a possible use of cholinergic drugs in pemphigus vulgaris. Antiinflamm Antiallergy Agents Med Chem. 2012;11:238-42.
  • Fortuna G, Marinkovich MP. Linear immunoglobulin: a bullous dermatosis. Clin Dermatol. 2012;30:38-50.
  • Fuertes de Vega I, Iranzo-Fernández P, Mascaró-Galy JM. Bullous Pemphigoid: clinical practice guidelines. Actas Dermosifiliogr. En prensa 2013.
  • Gupta R, Woodley DT, Chen M. Epidermolysis bullosa acquitsita. Clin Dermatol. 2012;30:60-9.
  • Gürcan HM, Ahmed AR. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data. Am J Clin Dermatol. 2009;10:383-96.
  • Herrero-González JE. Clinical guidelines for the diagnosis and treatment of dermatitis herpetiformis. Actas Dermosifiliogr. 2010; 101:820-6.
  • Intong LR, Murrell DF. Pemphigoid gestationis: current management. Dermatol Clin. 2011;29:621-8.
  • Mahajan VK, Sharma V, Chauhan PS, Mehta KS, Sharma AL, Abhinav C. Paraneoplastic pemphigus: a paraneoplastic autoimmune multiorgan syndrome or autoimmune multiorganopathy? Case Rep Dermatol Med. 2012;2012:1-6.
  • Moulin G, Barrut D, Franc MP, Viornery P, Knezynski S.Pseudopurpuric palmar localizations of herpetiform dermatitis. Ann Dermatol Venereol. 1983; 110:121-6.
  • Ruocco V, Ruocco E, Lo Schiavo A, Brunetti G, Guerrera LP, Wolf R. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol. 2013;31:374-81.
  • Saha M, Bhogal B, Black M, Cooper D, Vaughan R, Groves R. Prognostic factors in pemphigus vulgaris and pemphigus foliaceus. Br J Dermatol. En prensa 2013.
  • Schiavo AL, Puca RV, Ruocco V, Ruocco E. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: facts and controversias. Clinics in Dermatology. 2010;28:337-43.
  • Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381:320-32.
  • Suárez R, España A, Herrero-González JE, Iranzo P, Mascaró JM Jr. Management of autoimmune blistering diseases in Spain. Dermatol Clin. 2011;29:673-6.
  • Suárez-Fernández R, España-Alonso A, Herrero-González JE, Mascaró-Galy JM. Practical management of the most common autoimmune bullous diseases. Actas Dermosifiliogr. 2008;99:441-55.
  • Taghipour K, Chi CC, Bhogal B, Groves RW, Venning V, Wojnarowska F. Immunopathological characteristics of patients with bullous pemphigoid and neurological disease. J Eur Acad Dermatol Venereol. En prensa 2013.
  • Tosti A, André M, Murrell DF. Nail involvement in autoimmune bullous disorders. Dermatol Clin. 2011;29:511-3.
  • Veraitch O, Ohyama M, Yamagami J, Amagai M. Alopecia as a rare but distinct manifestation of pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2013;27:86-91.
  • Zhang D, Li X, Xiao S, Huo J, Wang S, Zhou P. Detection and comparison of two types of ATP2C1 gene mutations in Chinese patients with Hailey-Hailey disease. Arch Dermatol Res. 2012;304:163-70.
Data source: Dialnet